Get my own profile
Public access
View all9 articles
0 articles
available
not available
Based on funding mandates
Co-authors
- Nurit HaspelAssociate Professor of Computer Science, University of Massachusetts BostonVerified email at umb.edu
- David BarbieDana-Farber Cancer InstituteVerified email at partners.org
- Michael TolstorukovDana-Farber Cancer InstituteVerified email at mail.dfci.harvard.edu
- Erik KnelsonMerckVerified email at merck.com
- Kourosh ZarringhalamDepartment of Mathematics UMass BostonVerified email at umb.edu
- Matthew OserDana-Farber Cancer InstituteVerified email at dfci.harvard.edu
- Razvan CristescuDistinguished Scientist, MerckVerified email at merck.com
- Pasi JanneDana Farber Cancer InstituteVerified email at dfci.harvard.edu
- Andrey LobodaDirector, Computational and Systems Biology, MerckVerified email at merck.com
- Biagio RicciutiLowe Center for Thoracic Oncology, Dana-Farber Cancer InstituteVerified email at dfci.harvard.edu
- Tosha ShahMerckVerified email at merck.com
- Keith L. LigonAssociate Professor, Harvard Medical SchoolVerified email at dfci.harvard.edu
- Antong ChenExecutive Director, Data Science and Scientific Informatics, Merck & Co., Inc.Verified email at merck.com
- Kin-Hoe ChowSigilon Therapeutics, a wholly subsidiary of Eli Lilly and Company